FACULTY PUBLICATIONS - 2004 & 2005

1. Al-Quran, S. Z.; Al-Abbadi, M. and Braylan, R. C. "In Hematopathology, Love Is Everywhere." Arch Pathol Lab Med, 2004, 128(11), pp. 1309.

2. Ali, S.; El-Rayes, B. F.; Heilbrun, L. K.; Sarkar, F. H.; Ensley, J. F.; Kucuk, O. and Philip, P. A. "Cytochrome P450 and Glutathione Transferase Expression in Squamous Cell Cancer." Clin Cancer Res, 2004, 10(13), pp. 4412-6.

3. Ali, S.; El-Rayes, B. F.; Aranha, O.; Sarkar, F. H. and Philip, P. A. "Sequence Dependent Potentiation of Gemcitabine by Flavopiridol in Human Breast Cancer Cells." Breast Cancer Res Treat, 2005, 90(1), pp. 25-31.

4. Ali-Fehmi, R.; Morris, R. T.; Bandyopadhyay, S.; Che, M.; Schimp, V.; Malone, J. M., Jr. and Munkarah, A. R. "Expression of Cyclooxygenase-2 in Advanced Stage Ovarian Serous Carcinoma: Correlation with Tumor Cell Proliferation, Apoptosis, Angiogenesis, and Survival." Am J Obstet Gynecol, 2005, 192(3), pp. 819-25.

5. Bayerl, M. G.; Bentley, G.; Bellan, C.; Leoncini, L.; Ehmann, W. C. and Palutke, M. "Lacunar and Reed-Sternberg-Like Cells in Follicular Lymphomas Are Clonally Related to the Centrocytic and Centroblastic Cells as Demonstrated by Laser Capture Microdissection." Am J Clin Pathol, 2004, 122(6), pp. 858-64.

6. Bentley, G.; Palutke, M. and Mohamed, A. N. "Variant T(14;18) in Malignant Lymphoma: A Report of Seven Cases." Cancer Genet Cytogenet, 2005, 157(1), pp. 12-7.

7. Dong, Z.; Bonfil, R. D.; Chinni, S.; Deng, X.; Trindade Filho, J. C.; Bernardo, M.; Vaishampayan, U.; Che, M.; Sloane, B. F.; Sheng, S., et al. "Matrix Metalloproteinase Activity and Osteoclasts in Experimental Prostate Cancer Bone Metastasis Tissue." Am J Pathol, 2005, 166(4), pp. 1173-86.

8. El-Rayes, B. F.; Korkmaz, H.; Maciorowski, Z.; Sakr, W.; Jacobs, J. R. and Ensley, J. F. "Pseudoaneuploid Subpopulations Detected in Normal Upper Aerodigestive Tract Mucosa Consistent with Physiological Apoptosis in Normally Differentiating Squamous Mucosa." Otolaryngol Head Neck Surg, 2004, 131(5), pp. 633-8.

9. Fernandez-Madrid, F.; Tang, N.; Alansari, H.; Granda, J. L.; Tait, L.; Amirikia, K. C.; Moroianu, M.; Wang, X. and Karvonen, R. L. "Autoantibodies to Annexin Xi-a and Other Autoantigens in the Diagnosis of Breast Cancer." Cancer Res, 2004, 64(15), pp. 5089-96.

10. Fletcher, D. and Kleerekoper, M. "Neurologic Disease, Falls and Fractures." J Neurol Sci, 2004, 223(2), pp. 101-2.

11. Hegele, R. A. and Leff, T. "Unbuckling Lipodystrophy from Insulin Resistance and Hypertension." J Clin Invest, 2004, 114(2), pp. 163-5.

12. Kleerekoper, M. "The Further Evolution of Hyperparathyroidism: Implications for Clinical Care." Am J Med, 2004, 117(11), pp. 884-6.

13. Krakauer, J. C.; Franklin, B.; Kleerekoper, M.; Karlsson, M. and Levine, J. A. "Body Composition Profiles Derived from Dual-Energy X-Ray Absorptiometry, Total Body Scan, and Mortality." Prev Cardiol, 2004, 7(3), pp. 109-15.

14. Lawton, C. A.; Winter, K.; Grignon, D. and Pilepich, M. V. "Androgen Suppression Plus Radiation Versus Radiation Alone for Patients with Stage D1/Pathologic Node-Positive Adenocarcinoma of the Prostate: Updated Results Based on National Prospective Randomized Trial Radiation Therapy Oncology Group 85-31." J Clin Oncol, 2005, 23(4), pp. 800-7.

15. Linscott, A. J. and Brown, W. J. "Evaluation of Four Commercially Available Extended-Spectrum Beta-Lactamase Phenotypic Confirmation Tests." J Clin Microbiol, 2005, 43(3), pp. 1081-5.

16. Littrup, P. J.; Freeman-Gibb, L.; Andea, A.; White, M.; Amerikia, K. C.; Bouwman, D.; Harb, T. and Sakr, W. "Cryotherapy for Breast Fibroadenomas." Radiology, 2005, 234(1), pp. 63-72.

17. Liu, X. W.; Taube, M. E.; Jung, K. K.; Dong, Z.; Lee, Y. J.; Roshy, S.; Sloane, B. F.; Fridman, R. and Kim, H. R. "Tissue Inhibitor of Metalloproteinase-1 Protects Human Breast Epithelial Cells from Extrinsic Cell Death: A Potential Oncogenic Activity of Tissue Inhibitor of Metalloproteinase-1." Cancer Res, 2005, 65(3), pp. 898-906.

18. Nassar, H.; Pansare, V.; Zhang, H.; Che, M.; Sakr, W.; Ali-Fehmi, R.; Grignon, D.; Sarkar, F.; Cheng, J. and Adsay, V. "Pathogenesis of Invasive Micropapillary Carcinoma: Role of Muc1 Glycoprotein." Mod Pathol, 2004, 17(9), pp. 1045-50.

19. Peres, E.; Mattoo, T. K.; Poulik, J. and Warrier, I. "Primitive Neuroectodermal Tumor (Pnet) of the Uterus in a Renal Allograft Patient: A Case Report." Pediatr Blood Cancer, 2005, 44(3), pp. 283-5.

20. Pilepich, M. V.; Winter, K.; Lawton, C. A.; Krisch, R. E.; Wolkov, H. B.; Movsas, B.; Hug, E. B.; Asbell, S. O. and Grignon, D. "Androgen Suppression Adjuvant to Definitive Radiotherapy in Prostate Carcinoma--Long-Term Results of Phase Iii Rtog 85-31." Int J Radiat Oncol Biol Phys, 2005, 61(5), pp. 1285-90.

21. Powell, I. J.; Zhou, J.; Sun, Y.; Sakr, W. A.; Patel, N. P.; Heilbrun, L. K. and Everson, R. B. "Cyp3a4 Genetic Variant and Disease-Free Survival among White and Black Men after Radical Prostatectomy." J Urol, 2004, 172(5 Pt 1), pp. 1848-52.

21. Powell, I. J.; Land, S. J.; Dey, J.; Heilbrun, L. K.; Hughes, M. R.; Sakr, W. and Everson, R. B. "The Impact of Cag Repeats in Exon 1 of the Androgen Receptor on Disease Progression after Prostatectomy." Cancer, 2005, 103(3), pp. 528-37.

22. Prasad, A. S.; Bao, B.; Beck, F. W.; Kucuk, O. and Sarkar, F. H. "Antioxidant Effect of Zinc in Humans." Free Radic Biol Med, 2004, 37(8), pp. 1182-90.

23. Rahman, K. W. and Sarkar, F. H. "Inhibition of Nuclear Translocation of Nuclear Factor-{Kappa}B Contributes to 3,3'-Diindolylmethane-Induced Apoptosis in Breast Cancer Cells." Cancer Res, 2005, 65(1), pp. 364-71.

24. Raso, E.; Dome, B.; Somlai, B.; Zacharek, A.; Hagmann, W.; Honn, K. V. and Timar, J. "Molecular Identification, Localization and Function of Platelet-Type 12-Lipoxygenase in Human Melanoma Progression, under Experimental and Clinical Conditions." Melanoma Res, 2004, 14(4), pp. 245-50.

25. Reidy, P. M.; Dedo, H. H.; Rabah, R.; Field, J. B.; Mathog, R. H.; Gregoire, L. and Lancaster, W. D. "Integration of Human Papillomavirus Type 11 in Recurrent Respiratory Papilloma-Associated Cancer." Laryngoscope, 2004, 114(11), pp. 1906-9.

26. Shekhar, M. P.; Nangia-Makker, P.; Tait, L.; Miller, F. and Raz, A. "Alterations in Galectin-3 Expression and Distribution Correlate with Breast Cancer Progression: Functional Analysis of Galectin-3 in Breast Epithelial-Endothelial Interactions." Am J Pathol, 2004, 165(6), pp. 1931-41.

27. Siddiq, F.; Sarkar, F. H.; Wali, A.; Pass, H. I. and Lonardo, F. "Increased Osteonectin Expression Is Associated with Malignant Transformation and Tumor Associated Fibrosis in the Lung." Lung Cancer, 2004, 45(2), pp. 197-205.

28. Sumigama, S.; Ito, T.; Kajiyama, H.; Shibata, K.; Tamakoshi, K.; Kikkawa, F.; Williams, T.; Tainsky, M. A.; Nomura, S. and Mizutani, S. "Suppression of Invasion and Peritoneal Carcinomatosis of Ovarian Cancer Cells by Overexpression of Ap-2alpha." Oncogene, 2004, 23(32), pp. 5496-504.

29. Tsutsumi, S.; Yanagawa, T.; Shimura, T.; Kuwano, H. and Raz, A. "Autocrine Motility Factor Signaling Enhances Pancreatic Cancer Metastasis." Clin Cancer Res, 2004, 10(22), pp. 7775-84.

30. Williams, H.; Powell, I. J.; Land, S. J.; Sakr, W. A.; Hughes, M. R.; Patel, N. P.; Heilbrun, L. K. and Everson, R. B. "Vitamin D Receptor Gene Polymorphisms and Disease Free Survival after Radical Prostatectomy." Prostate, 2004, 61(3), pp. 267-75.

31. Yoo, G. H.; Piechocki, M. P.; Oliver, J.; Lonardo, F.; Zumstein, L.; Lin, H. S.; Kim, H.; Shibuya, T. Y.; Shehadeh, N. and Ensley, J. F. "Enhancement of Ad-P53 Therapy with Docetaxel in Head and Neck Cancer." Laryngoscope, 2004, 114(11), pp. 1871-9.

32. Zeleniuch-Jacquotte, A.; Adlercreutz, H.; Shore, R. E.; Koenig, K. L.; Kato, I.; Arslan, A. A. and Toniolo, P. "Circulating Enterolactone and Risk of Breast Cancer: A Prospective Study in New York." Br J Cancer, 2004, 91(1), pp. 99-105.

33. Zhe, X. and Schuger, L. "Combined Smooth Muscle and Melanocytic Differentiation in Lymphangioleiomyomatosis." J Histochem Cytochem, 2004, 52(12), pp. 1537-42.

34. Zhe, X.; Yang, Y. and Schuger, L. "Imbalanced Plasminogen System in Lymphangioleiomyomatosis: Potential Role of Serum Response Factor." Am J Respir Cell Mol Biol, 2005, 32(1), pp. 28-34.

35. Chakravarti A; Winter K; Wu CL; Kaufman D; Hammond E; Parliament M; Tester W; Hagan M; Grignon D; Heney N; Pollack A; Sandler H and Shipley W.. “Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: A report from the Radiation Therapy Oncology Group.” Int J Radiat Oncol Biol Phys. 2005 Jun 1; 62(2): 309-17.

36. Che M and Grignon DJ. “Handling and reporting of tumor-containing kidney specimens.” Clin Lab Med. 2005 Jun; 25 (2): 417-32.

37. Grignon DJ and Che M. “Clear cell renal cell carcinoma.” Clin Lab Med. 2005 Jun; 25 (2): 305-16.

38. Altinok G; Kattar MM; Mohamed A; Poulik J; Grignon D and Rabah R. “Pediatric Renal Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions and Clinicopathologic Associations.” Pediatr Dev Pathol. 2005 Mar 8; [Epub ahead of print]

39. Lawton CA; Winter K; Grignon D and Pilepich MV. “Androgen suppression plus radiation versus radiation alone for patients with stage D1/pathologic node-positive adenocarcinoma of the prostate: updated results based on national prospective randomized trial Radiation Therapy Oncology Group 85-31.” J Clin Oncol. 2005 Feb 1; 23 (4): 800-7.

40. Bismar TA; Humphrey PA; Grignon DJ and Wang HL. “Expression of beta-catenin in prostatic adenocarcinomas: a comparison with colorectal adenocarcinomas.” Am J Clin Pathol. 2004 Apr; 121 (4): 557-63.

41. Li R; Heydon K; Hammond ME; Grignon DJ; Roach M 3rd; Wolkov HB; Sandler HM; Shipley WU and Pollack A. “Ki-67 staining index predicts distant metastasis and survival in locally advanced prostate cancer treated with radiotherapy: an analysis of patients in radiation therapy oncology group protocol 86-10.” Clin Cancer Res. 2004 Jun 15; 10 (12 Pt 1): 4118-24.

42. Bianco FJ Jr; Justa D; Grignon DJ; Sakr WA; Pontes JE and Wood DP Jr. “Management of clinical T1 bladder transitional cell carcinoma by radical cystectomy.” Urol Oncol. 2004 Jul-Aug; 22 (4): 290-4.

43. McKenney JK; Amin MB; Srigley JR; Jimenez RE; Ro JY; Grignon DJ and Young RH. “Basal cell proliferations of the prostate other than usual basal cell hyperplasia: a clinicopathologic study of 23 cases, including four carcinomas, with a proposed classification.” Am J Surg Pathol. 2004 Oct; 28(10): 1289-98.

44. Adsay NV; Basturk O; Bonnett M; Kilinc N; Andea AA; Feng J; Che M; Aulicino MR; Live E and Cheng JD. “A proposal for a New and More Practical Grading Scheme for Pancreatic Ductal Adenocarcinoma.” Am J Surg Pathol. 2005 Jun; 29(6): 724-733.

45. Cao D; Maitra A; Saavedra JA; Klimstra DS; Adsay NV and Hruban RH. “Expression of novel markers of pancreatic ductal adenocarcinoma in pancreatic nonductal neoplasms: additional evidence of different genetic pathways.” Mod Pathol. 2005 Jun; 18(6): 752-61.

46. Hruban RH; Takaori K; Klimstra DS; Adsay NV; Albos-Saavedra J; Biankin AV; Biankin SA; Compton C; Fukushima N; Furukawa T; Goggins M; Kato Y; Kloppel G; Longnecker DS; Luttges J; Maitra A; Offerhaus GJ; Shimizu M and Yonezawa S. “An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms.” Am J Surg Pathol. 2004 Aug; 28(8); 977-87.

47. Adsay NV; Merati K; Basturk O; Iacobuzio-Donahue C; Levi E; Cheng JD; Sarkar FH; Hruban RH and Klimstra DS. “Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an “intestinal” pathway of carcinogenesis in the pancreas.” Am J Surg Pathol. 2004 Jul; 28(7); 839-48.

48. Bismar TA; Basturk O; Gerald WL; Schwarz K and Adsay NV. “Desmoplastic small cell tumor in the pancreas.” Am J Surg Pathol. 2004 Jun; 28(6); 808-12.

49. Levi E; Klimstra DS; Andea A; Basturk O and Adsay NV. “MUC1 and MUC2 in pancreatic neoplasia.” J Clin Pathol. 2004 May; 57(5): 456-62. Erratum in: J Clin Pathol. 2004 Jul; 57(7): 784.

50. Adsay NV; Andea A; Basturk O; Kilinc N; Nassar H and Cheng JD. “Secondary tumors of the pancreas: an analysis of a surgical and autopsy database and review of the literature.” Virchows Arch. 2004 Jun; 444(6): 527-35. Epub 2004 Apr 1.

FACULTY PUBLICATIONS - 2003 & 2004

1. Abdulhamid I and Rabah R: Endobronchial chondromatous hamartoma in an infant. Pediatr Pulmonol. 35: 67-9, 2003.

2. Adsay NV, Merati K, Nassar H, Shia J, Sarkar F, Pierson CR, Cheng JD, Visscher DW, Hruban RH and Klimstra DS: Pathogenesis of colloid (pure mucinous) carcinoma of exocrine organs: Coupling of gel-forming mucin (MUC2) production with altered cell polarity and abnormal cell-stroma interaction may be the key factor in the morphogenesis and indolent behavior of colloid carcinoma in the breast and pancreas. Am J Surg Pathol. 27: 571-8, 2003.

3. Al-Abbadi MA and Saleh H: Dedicating specific sessions of cytopathology courses to medical students. A survey/consensus study. Acta Cytol. 48: 13-6, 2004.

4. Al-Sukhun S, Zalupski MM, Ben-Josef E, Vaitkevicius VK, Philip PA, Soulen R, Weaver D, Adsay V, Heilbrun LK, Levin K et al.: Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study. Am J Clin Oncol. 26: 543-9, 2003.

5. Ali S, Aranha O, Li Y, Pettit GR, Sarkar FH and Philip PA: Sensitization of human breast cancer cells to gemcitabine by the protein kinase C modulator bryostatin 1. Cancer Chemother Pharmacol. 52: 235-46, 2003.

6. Ali-Fehmi R, Che M, Khalifeh I, Malone JM, Morris R, Lawrence WD and Munkarah AR: The effect of cyclooxygenase-2 expression on tumor vascularity in advanced stage ovarian serous carcinoma. Cancer. 98: 1423-9, 2003.

7. Ali-Fehmi R, Carolin K, Wallis T and Visscher DW: Clinicopathologic analysis of breast lesions associated with multiple papillomas. Hum Pathol. 34: 234-9, 2003.

8. Ali-Fehmi R, Che M, Khalifeh I, Malone JM, Morris R, Lawrence WD and Munkarah AR: The effect of cyclooxygenase-2 expression on tumor vascularity in advanced stage ovarian serous carcinoma. Cancer. 98: 1423-9, 2003.

9. Ali-Fehmi R, Qureshi F, Lawrence WD and Jacques SM: Apoptosis, proliferation, and expression of p53 and bcl-2 in endocervical glandular intraepithelial lesions and invasive endocervical adenocarcinoma. Int J Gynecol Pathol. 23: 1-6, 2004.

10. Amin MB, Srigley JR, Grignon DJ, Reuter VE, Humphrey PA, Cohen MB and Hammond ME: Updated protocol for the examination of specimens from patients with carcinoma of the urinary bladder, ureter, and renal pelvis. Arch Pathol Lab Med. 127: 1263-79, 2003.

11. An T and Tabaczka P: The use of polarization microscopy in the diagnosis of pneumocystis pneumonia. Arch Pathol Lab Med. 128: 363-4, 2004.

12. Andea A, Sarkar F and Adsay VN: Clinicopathological correlates of pancreatic intraepithelial neoplasia: a comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarcinoma. Mod Pathol. 16: 996-1006, 2003.

13. Aranha O, Grignon R, Fernandes N, McDonnell TJ, Wood DP, Jr. and Sarkar FH: Suppression of human prostate cancer cell growth by ciprofloxacin is associated with cell cycle arrest and apoptosis. Int J Oncol. 22: 787-94, 2003.

14. Bakhshi S, Hamre M, Mohamed AN, Feldman G and Ravindranath Y: t(5;9)(q11;q34): a novel familial translocation involving Abelson oncogene and association with hypereosinophilia. J Pediatr Hematol Oncol. 25: 82-4, 2003.

15. Barnholtz-Sloan JS, Schwartz AG, Qureshi F, Jacques S, Malone J and Munkarah AR: Ovarian cancer: changes in patterns at diagnosis and relative survival over the last three decades. Am J Obstet Gynecol. 189: 1120-7, 2003.

16. Bartrand AJ, Iyasu D and Brush GS: DNA Stimulates Mec1-mediated Phosphorylation of Replication Protein A. J Biol Chem. 279: 26762-7, 2004.

17. Baylor AE, 3rd, Diebel LN, Liberati DM, Dulchavsky SA, Brown WJ and Diglio CA: The synergistic effects of hypoxia/reoxygenation or tissue acidosis and bacteria on intestinal epithelial cell apoptosis. J Trauma. 55: 241-7; discussion 247-8, 2003.

18. Baylor AE, Diebel LN, Liberati DM, Dulchavsky SA, Diglio CA and Brown WJ: The effects of varying oxygenconditions and immunoglobulin A on barrier defense to bacterial invasion. Am Surg. 69: 231-7; discussion 237, 2003.

19. Beck FW, Prasad AS, Butler CE, Sakr WA, Kucuk O and Sarkar FH: Differential expression of hZnT-4 in human prostate tissues. Prostate. 58: 374-81, 2004.

20. Bernardo MM and Fridman R: TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP. Biochem J. 374: 739-45, 2003.

21. Bhathena DB: Glomerular basement membrane length to podocyte ratio in human nephronopenia: implications for focal segmental glomerulosclerosis. Am J Kidney Dis. 41: 1179-88, 2003.

22. Bianco FJ, Grignon DJ, Sakr WA, Shekarriz B, Upadhyay J, Dornelles E and Pontes JE: Radical prostatectomy with bladder neck preservation: impact of a positive margin. Eur Urol. 43: 461-6, 2003.

23. Bianco FJ, Jr., Wood DP, Jr., Cher ML, Powell IJ, Souza JW and Pontes JE: Ten-year survival after radical prostatectomy: specimen Gleason score is the predictor in organ-confined prostate cancer. Clin Prostate Cancer. 1:242-7, 2003.

24. Bianco FJ, Grignon DJ, Sakr WA, Shekarriz B, Upadhyay J, Dornelles E and Pontes JE: Radical prostatectomy with bladder neck preservation: impact of a positive margin. Eur Urol. 43: 461-6, 2003.

25. Bismar TA, Bianco FJ, Zhang H, Li X, Sarkar FH, Sakr WA, Grignon DJ and Che M: Quantification of G250 mRNA expression in renal epithelial neoplasms by real-time reverse transcription-PCR of dissected tissue from paraffin sections. Pathology. 35: 513-7, 2003.

26. Bismar TA, Humphrey PA, Grignon DJ and Wang HL: Expression of beta-catenin in prostatic adenocarcinomas: a comparison with colorectal adenocarcinomas. Am J Clin Pathol. 121: 557-63, 2004.

27. Blancato J, Singh B, Liu A, Liao DJ and Dickson RB: Correlation of amplification and overexpression of the c-myc oncogene in high-grade breast cancer: FISH, in situ hybridisation and immunohistochemical analyses. Br J Cancer. 90: 1612-9, 2004.

28. Bonfil RD, Osenkowski P, Fridman R and Cher ML: Matrix metalloproteinaes and bone metastasis. Cancer Treat Res. 118: 173-95, 2004.

29. Calhoun ES, Jones JB, Ashfaq R, Adsay V, Baker SJ, Valentine V, Hempen PM, Hilgers W, Yeo CJ, Hruban RH et al.: BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) mutations in distinct subsets of pancreatic cancer: potential therapeutic targets. Am J Pathol. 163: 1255-60, 2003.

30. Chakrabarti S, Khan ZA, Cukiernik M, Zhang W and Sima AA: C-peptide and retinal microangiopathy in diabetes. Exp Diabesity Res. 5: 91-6, 2004.

31. Che M, Sakr W and Grignon D: Pathologic features the urologist should expect on a prostate biopsy. Urol Oncol. 21: 153-61, 2003.

32. Cher ML, Biliran HR, Jr., Bhagat S, Meng Y, Che M, Lockett J, Abrams J, Fridman R, Zachareas M and Sheng S: Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis. Proc Natl Acad Sci U S A. 100: 7847-52, 2003.

33. Chinni SR, Alhasan SA, Multani AS, Pathak S and Sarkar FH: Pleotropic effects of genistein on MCF-7 breast cancer cells. Int J Mol Med. 12: 29-34, 2003.

34. Clifford DM, Marinco SM and Brush GS: The meiosis-specific protein kinase Ime2 directs phosphorylation of replication protein A. J Biol Chem. 279: 6163-70, 2004.

35. Culhaci N, Levi E, Sen S, Kacar F and Meteoglu I: Pulmonary lymphomatoid granulomatosis evolving to large cell lymphoma in the skin. Pathol Oncol Res. 8: 280-2, 2002.

36. Diebel LN, Liberati DM, Dulchavsky SA, Diglio CA and Brown WJ: Enterocyte apoptosis and barrier function are modulated by SIgA after exposure to bacteria and hypoxia/reoxygenation. Surgery. 134: 574-80; discussion 580-1, 2003.

37. Dolgachev V, Farooqui MS, Kulaeva OI, Tainsky MA, Nagy B, Hanada K and Separovic D: De novo ceramide accumulation due to inhibition of its conversion to complex sphingolipids in apoptotic photosensitized cells. J Biol Chem. 279: 23238-49, 2004.

38. Draghici S, Kulaeva O, Hoff B, Petrov A, Shams S and Tainsky MA: Noise sampling method: an ANOVA approach allowing robust selection of differentially regulated genes measured by DNA microarrays. Bioinformatics. 19: 1348-59, 2003.

39. Draghici S, Khatri P, Bhavsar P, Shah A, Krawetz SA and Tainsky MA: Onto-Tools, the toolkit of the modern biologist: Onto-Express, Onto-Compare, Onto-Design and Onto-Translate. Nucleic Acids Res. 31: 3775-81, 2003.

40. Draghici S, Khatri P, Shah A and Tainsky MA: Assessing the functional bias of commercial microarrays using the onto-compare database. Biotechniques. Suppl: 55-61, 2003.

41. Dryden SC, Nahhas FA, Nowak JE, Goustin AS and Tainsky MA: Role for human SIRT2 NAD-dependent deacetylaseactivity in control of mitotic exit in the cell cycle. Mol Cell Biol. 23: 3173-85, 2003.

42. El-Rayes BF, Zalupski MM, Shields AF, Vaishampayan U, Heilbrun LK, Jain V, Adsay V, Day J and Philip PA: Phase II study of gemcitabine, cisplatin, and infusional fluorouracil in advanced pancreatic cancer. J Clin Oncol. 21: 2920-5, 2003.

43. Farhana L, Dawson MI, Huang Y, Zhang Y, Rishi AK, Reddy KB, Freeman RS and Fontana JA: Apoptosis signaling by the novel compound 3-Cl-AHPC involves increased EGFR proteolysis and accompanying decreased phosphatidylinositol 3-kinase and AKT kinase activities. Oncogene. 23: 1874-84, 2004.

44. Fridman R, Toth M, Chvyrkova I, Meroueh SO and Mobashery S: Cell surface association of matrix metalloproteinase-9 (gelatinase B). Cancer Metastasis Rev. 22: 153-66, 2003.

45. Fridman R: Surface association of secreted matrix metalloproteinases. Curr Top Dev Biol. 54: 75-100, 2003.

46. Fukumori T, Takenaka Y, Yoshii T, Kim HR, Hogan V, Inohara H, Kagawa S and Raz A: CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis. Cancer Res. 63: 8302-11, 2003.

47. Fukumori T, Takenaka Y, Oka N, Yoshii T, Hogan V, Inohara H, Kanayama HO, Kim HR and Raz A: Endogenous galectin-3 determines the routing of CD95 apoptotic signaling pathways. Cancer Res. 64: 3376-9, 2004.

48. Glazyrin AL, Kan-Mitchell J and Mitchell ML: Analysis of in vitro immunization: generation of cytotoxic T-lymphocytes against allogeneic melanoma cells with tumor lysate-loaded or tumor RNA-transfected antigen-presenting cells. Cancer Immunol Immunother. 52: 171-8, 2003.

49. Gong L, Li Y, Nedeljkovic-Kurepa A and Sarkar FH: Inactivation of NF-kappaB by genistein is mediated via Akt signaling pathway in breast cancer cells. Oncogene. 22: 4702-9, 2003.

50. Gregoire L, Reidy PM, Rabah R and Lancaster WD: HLA-DQ alleles in white and African American patients with juvenile-onset recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg. 129: 1221-4, 2003.

51. Grignon DJ: Unusual subtypes of prostate cancer. Mod Pathol. 17: 316-27, 2004.

52. Grunberger G and Sima AA: The C-peptide signaling. Exp Diabesity Res. 5: 25-36, 2004.

53. Hanks GE, Pajak TF, Porter A, Grignon D, Brereton H, Venkatesan V, Horwitz EM, Lawton C, Rosenthal SA, Sandler HM et al.: Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02. J Clin Oncol. 21: 3972-8, 2003.

54. Heng HH, Ye CJ, Yang F, Ebrahim S, Liu G, Bremer SW, Thomas CM, Ye J, Chen TJ, Tuck-Muller C et al.: Analysis of marker or complex chromosomal rearrangements present in pre- and post-natal karyotypes utilizing a combination of G-banding, spectral karyotyping and fluorescence in situ hybridization. Clin Genet. 63: 358-67, 2003.

55. Heng HH, Goetze S, Ye CJ, Liu G, Stevens JB, Bremer SW, Wykes SM, Bode J and Krawetz SA: Chromatin loops are selectively anchored using scaffold/matrix-attachment regions. J Cell Sci. 117: 999-1008, 2004.

56. Heng HH, Stevens JB, Liu G, Bremer SW and Ye CJ: Imaging genome abnormalities in cancer research. Cell Chromosome. 3: 1, 2004.

57. Hillman GG, Maughan RL, Grignon DJ, Yudelev M, Che M, Abrams J, Wang Y, Layer A, Wright JL, Rubio J et al.: Responsiveness of experimental prostate carcinoma bone tumors to neutron or photon radiation combined with cytokine therapy. Int J Radiat Oncol Biol Phys. 56: 1426-37, 2003.

58. Hodgson SF, Watts NB, Bilezikian JP, Clarke BL, Gray TK, Harris DW, Johnston CC, Jr., Kleerekoper M, Lindsay R, Luckey MM et al.: American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. Endocr Pract. 9: 544-64, 2003.

59. Hong YH, Varanasi US, Yang W and Leff T: AMP-activated protein kinase regulates HNF4alpha transcriptional activity by inhibiting dimer formation and decreasing protein stability. J Biol Chem. 278: 27495-501, 2003.

60. Hong X, Li Y, Hussain M and Sarkar FH: Gene expression profiling reveals novel targets of estramustine phosphate in prostate cancer cells. Cancer Lett. 209: 187-95, 2004.

61. Hussain M, Banerjee M, Sarkar FH, Djuric Z, Pollak MN, Doerge D, Fontana J, Chinni S, Davis J, Forman J et al.: Soy isoflavones in the treatment of prostate cancer. Nutr Cancer. 47: 111-7, 2003.

62. Hussain M, Smith DC, El-Rayes BF, Du W, Vaishampayan U, Fontana J, Sakr W and Wood D: Neoadjuvant docetaxel and estramustine chemotherapy in high-risk/locallyadvanced prostate cancer. Urology. 61: 774-80, 2003.

63. Inaba H, Rabah R, Meert KL and BhamBhani K: Herpes simplex virus pneumonia in a patient with ependymoma. J Pediatr Hematol Oncol. 26: 108-11, 2004.

64. Jacques SM and Qureshi F: Adrenocortical and hepatic nodules within placental tissue. Pediatr Dev Pathol. 6: 464-6, 2003.

65. Jacques SM, Qureshi F, Johnson A, Alkatib AA and Kmak DC: Estimation of time of fetal death in the second trimester by placental histopathological examination. Pediatr Dev Pathol. 6: 226-32, 2003.

66. Jakkaraju S, Zhe X and Schuger L: Role of stretch in activation of smooth muscle cell lineage. Trends Cardiovasc Med. 13: 330-5, 2003.

67. Jiao J, Greendorfer JS, Zhang P, Zinn KR, Diglio CA and Thompson JA: Alternatively spliced FGFR-1 isoform signaling differentially modulates endothelial cell responses to peroxynitrite. Arch Biochem Biophys. 410: 187-200, 2003.

68. Kacar F, Meteoglu I, Sen S and Levi E: Primary neuroendocrine carcinoma of the mediastinum. Pathol Oncol Res. 8: 200-1, 2002.

69. Kalache KD, Romero R, Conoscenti G, Qureshi F, Jacques SM, Chaiworapongsa T, Treadwell M and Johnson A: Prenatal diagnosis of dilated coronary sinus with persistent left superior vena cava in a fetus with trisomy 18. Prenat Diagn. 23: 108-10, 2003.

70. Kan-Mitchell J, Bisikirska B, Wong-Staal F, Schaubert KL, Bajcz M and Bereta M: The HIV-1 HLA-A2-SLYNTVATL is a help-independent CTL epitope. J Immunol. 172: 5249-61, 2004.

71. Kandouz M, Nie D, Pidgeon GP, Krishnamoorthy S, Maddipati KR and Honn KV: Platelet-type 12-lipoxygenase activates NF-kappaB in prostate cancer cells. Prostaglandins Other Lipid Mediat. 71: 189-204, 2003.

72. Kazzi SN, Jacques SM, Qureshi F, Quasney MW, Kim UO and Buhimschi IA: Tumor Necrosis Factor-{alpha} Allele Lymphotoxin-{alpha}+250 Is Associated with the Presence and Severity of Placental Inflammation among Preterm Births. Pediatr Res, 2004.

73. Khalifeh I, Munkarah AR, Lonardo F, Malone JM, Morris R, Lawrence WD and Ali-Fehmi R: Expression of Cox-2, CD34, Bcl-2, and p53 and survival in patients with primary peritoneal serous carcinoma and primary ovarian serous carcinoma. Int J Gynecol Pathol. 23: 162-9, 2004.

74. Kleerekoper M: Treatment of Osteoporosis. Clin Obstet Gynecol. 47: 413-423, 2004.

75. Kruger JS and Reddy KB: Distinct mechanisms mediate the initial and sustained phases of cell migration inepidermal growth factor receptor-overexpressing cells. Mol Cancer Res. 1: 801-9, 2003.

76. Kulaeva OI, Draghici S, Tang L, Kraniak JM, Land SJ and Tainsky MA: Epigenetic silencing of multiple interferon pathway genes after cellular immortalization. Oncogene. 22: 4118-27, 2003.

77. L'Ecuyer T, Allebban Z, Thomas R and Vander Heide R: Glutathione S-transferase overexpression protects against anthracycline-induced H9C2 cell death. Am J Physiol Heart Circ Physiol. 286: H2057-64, 2004.

78. Leff T: AMP-activated protein kinase regulates gene expression by direct phosphorylation of nuclear proteins. Biochem Soc Trans. 31: 224-7, 2003.

79. Levi E, Klimstra DS, Adsay NV, Andea A and Basturk O: MUC1 and MUC2 in pancreatic neoplasia. J Clin Pathol. 57: 456-62, 2004.

80. Li ZG, Zhang W and Sima AA: C-peptide enhances insulin-mediated cell growth and protection against high glucose-induced apoptosis in SH-SY5Y cells. Diabetes Metab Res Rev. 19: 375-85, 2003.

81. Li Y, Ali S, Philip PA and Sarkar FH: Direct comparison of microarray gene expression profiles between non-amplification and a modified cDNA amplification procedure applicable for needle biopsy tissues. Cancer Detect Prev.27: 405-11, 2003.

82. Li Y, Li X and Sarkar FH: Gene expression profiles of I3C- and DIM-treated PC3 human prostate cancer cells determined by cDNA microarray analysis. J Nutr. 133: 1011-9, 2003.

83. Li ZG and Sima AA: C-peptide and central nervous system complications in diabetes. Exp Diabesity Res. 5: 79-90, 2004.

84. Li Y, Li X, Hussain M and Sarkar FH: Regulation of microtubule, apoptosis, and cell cycle-related genes by taxotere in prostate cancer cells analyzed by microarray. Neoplasia. 6: 158-67, 2004.

85. Li Y, Ellis KL, Ali S, El-Rayes BF, Nedeljkovic-Kurepa A, Kucuk O, Philip PA and Sarkar FH: Apoptosis-inducing effect of chemotherapeutic agents is potentiated by soy isoflavone genistein, a natural inhibitor of NF-kappaB in BxPC-3 pancreatic cancer cell line. Pancreas. 28: e90-5, 2004.

86. Liao DJ, Du QQ, Yu BW, Grignon D and Sarkar FH: Novel perspective: focusing on the X chromosome in reproductive cancers. Cancer Invest. 21: 641-58, 2003.

87. Liu XW, Bernardo MM, Fridman R and Kim HR: Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells against intrinsic apoptotic cell death via the focal adhesion kinase/phosphatidylinositol 3-kinase and MAPK signaling pathway. J Biol Chem. 278: 40364-72, 2003.

88. Lonardo F, Pass HI and Lucas DR: Immunohistochemistry frequently detects c-Kit expression in pulmonary small cell carcinoma and may help select clinical subsets for a novel form of chemotherapy. Appl Immunohistochem Mol Morphol. 11: 51-5, 2003.

89. Lorincz A, Haddad D, Naik R, Naik V, Fung A, Cao A, Manda P, Pandya A, Auner G, Rabah R et al.: Raman spectroscopy for neoplastic tissue differentiation: A pilot study. J Pediatr Surg. 39: 953-6, 2004.

90. Lorincz A, Knight CG, Langenburg SE, Rabah R, Gidell K, Dawe E, Grant S and Klein MD: Robot-assisted minimally invasive Kasai portoenterostomy: a survival porcine study. Surg Endosc, 2004.

91. Lucas DR, Al-Abbadi M, Tabaczka P, Hamre MR, Weaver DW and Mott MJ: c-Kit expression in desmoid fibromatosis. Comparative immunohistochemical evaluation of two commercial antibodies. Am J Clin Pathol. 119: 339-45, 2003.

92. Lucas DR, Pass HI, Madan SK, Adsay NV, Wali A, Tabaczka P and Lonardo F: Sarcomatoid mesothelioma and its histological mimics: a comparative immunohistochemical study. Histopathology. 42: 270-9, 2003.

93. Majumdar AP, Du J, Hatfield JS, Levi E, Adsay V, Schmelz EM, Nagothu KK, Jaszewski R, Kucuk O and Sarkar FH: Expression of EGF-receptor related protein (ERRP) decreases in gastric mucosa during aging and carcinogenesis. Dig Dis Sci. 48: 856-64, 2003.

94. Marciniak DJ, Moragoda L, Mohammad RM, Yu Y, Nagothu KK, Aboukameel A, Sarkar FH, Adsay VN, Rishi AK and Majumdar AP: Epidermal growth factor receptor-related protein: a potential therapeutic agent for colorectal cancer. Gastroenterology. 124: 1337-47, 2003.

95. Mitchell MS, Kan-Mitchell J, Morrow PR, Darrah D, Jones VE and Mescher MF: Phase I trial of large multivalent immunogen derived from melanoma lysates in patients with disseminated melanoma. Clin Cancer Res. 10: 76-83, 2004.

96. Mohamed AN, Pemberton P, Zonder J and Schiffer CA: The effect of imatinib mesylate on patients with Philadelphia chromosome-positive chronic myeloid leukemia with secondary chromosomal aberrations. Clin Cancer Res. 9: 1333-7, 2003.

97. Mohammad RM, Al-Katib A, Aboukameel A, Doerge DR, Sarkar F and Kucuk O: Genistein sensitizes diffuse large cell lymphoma to CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy. Mol Cancer Ther. 2: 1361-8, 2003.

98. Nassar H, Ali-Fehmi R and Madan S: Use of ThinPrep monolayer technique and cytospin preparation in urine cytology: a comparative analysis. Diagn Cytopathol. 28: 115-8, 2003.

99. Nassar H, Pansare V, Zhang H, Che M, Sakr W, Ali-Fehmi R, Grignon D, Sarkar F, Cheng J and Adsay V: Pathogenesis of invasive micropapillary carcinoma: role of MUC1 glycoprotein. Mod Pathol, 2004.

100. Nemeth JA, Cher ML, Zhou Z, Mullins C, Bhagat S and Trikha M: Inhibition of alpha(v)beta3 integrin reduces angiogenesis, bone turnover, and tumor cell proliferation in experimental prostate cancer bone metastases. Clin Exp Metastasis. 20: 413-20, 2003.

101. Newman LA, Pernick NL, Adsay V, Carolin KA, Philip PA, Sipierski S, Bouwman DL, Kosir MA, White M and Visscher DW: Histopathologic evidence of tumor regression in the axillary lymph nodes of patients treated with preoperative chemotherapy correlates with breast cancer outcome. Ann Surg Oncol. 10: 734-9, 2003.

102. Nie D, Nemeth J, Qiao Y, Zacharek A, Li L, Hanna K, Tang K, Hillman GG, Cher ML, Grignon DJ et al.: Increased metastatic potential in human prostate carcinoma cells by overexpression of arachidonate 12-lipoxygenase. Clin Exp Metastasis. 20: 657-63, 2003.

103. Nie D, Che M, Zacharek A, Qiao Y, Li L, Li X, Lamberti M, Tang K, Cai Y, Guo Y et al.: Differential expression of thromboxane synthase in prostate carcinoma: role in tumor cell motility. Am J Pathol. 164: 429-39, 2004.

104. Nie D and Honn KV: Eicosanoid regulation of angiogenesis in tumors. Semin Thromb Hemost. 30: 119-25, 2004.

105. Oka N, Takenaka Y and Raz A: Galectins and urological cancer. J Cell Biochem. 91: 118-24, 2004.

106. Olopade OI, Fackenthal JD, Dunston G, Tainsky MA, Collins F and Whitfield-Broome C: Breast cancer genetics in African Americans. Cancer. 97: 236-45, 2003.

107. Onishi Y, Tsukada K, Yokota J and Raz A: Overexpression of autocrine motility factor receptor (AMFR) in NIH3T3 fibroblasts induces cell transformation. Clin Exp Metastasis. 20: 51-8, 2003.

108. Osenkowski P, Toth M and Fridman R: Processing, shedding, and endocytosis of membrane type 1-matrix metalloproteinase (MT1-MMP). J Cell Physiol. 200: 2-10, 2004.

109. Paliwal S, Shi J, Dhru U, Zhou Y and Schuger L: P311 binds to the latency associated protein and downregulates the expression of TGF-beta1 and TGF-beta2. Biochem Biophys Res Commun. 315: 1104-9, 2004.

110. Papas P and Al-Abbadi MA: Pathologic quiz case: a 32-year-old Western-Indian woman with a history of chronic abdominal pain and a cystic mass of pancreas. Mucinous cystic neoplasm, adenoma type. Arch Pathol Lab Med. 128: e54-5, 2004.

111. Pass HI, Liu Z, Wali A, Bueno R, Land S, Lott D, Siddiq F, Lonardo F, Carbone M and Draghici S: Gene expression profiles predict survival and progression of pleural mesothelioma. Clin Cancer Res. 10: 849-59, 2004.

112. Peres EM, Savasan S, Cushing B, Abella S and Mohamed AN: Chromosome analyses of 16 cases of Wilms tumor:different pattern in unfavorable histology. Cancer Genet Cytogenet. 148: 66-70, 2004.

113. Pernick NL, Sarkar FH, Philip PA, Arlauskas P, Shields AF, Vaitkevicius VK, Dugan MC and Adsay NV: Clinicopathologic analysis of pancreatic adenocarcinoma in African Americans and Caucasians. Pancreas. 26: 28-32, 2003.

114. Petrov T, Rafols JA, Alousi SS, Kupsky WJ, Johnson R, Shah J, Shah A and Watson C: Cellular compartmentalization of phosphorylated eIF2alpha and neuronal NOS in human temporal lobe epilepsy with hippocampal sclerosis. J Neurol Sci. 209: 31-9, 2003.

115. Pidgeon GP, Tang K, Cai YL, Piasentin E and Honn KV: Overexpression of platelet-type 12-lipoxygenase promotes tumor cell survival by enhancing alpha(v)beta(3) and alpha(v)beta(5) integrin expression. Cancer Res. 63: 4258-67, 2003.

116. Pidgeon GP, Tang K, Rice RL, Zacharek A, Li L, Taylor JD and Honn KV: Overexpression of leukocyte-type 12-lipoxygenase promotes W256 tumor cell survival by enhancing alphavbeta5 expression. Int J Cancer. 105: 459-71, 2003.

117. Pierson CR, Zhang W and Sima AA: Proinsulin C-peptide replacement in type 1 diabetic BB/Wor-rats prevents deficits in nerve fiber regeneration. J Neuropathol Exp Neurol. 62: 765-79, 2003.

118. Pierson CR, Zhang W, Murakawa Y and Sima AA: Insulin deficiency rather than hyperglycemia accounts for impaired neurotrophic responses and nerve fiber regeneration in type 1 diabetic neuropathy. J Neuropathol Exp Neurol.62: 260-71, 2003.

119. Pilepich MV, Winter K, Lawton C, Krisch RE, Wolkov H, Movsas B, Hug E, Asbell S and Grignon D: Androgen suppression adjuvant to radiotherapy in carcinoma of the prostate. long-term results of phase III RTOG study 85-31. Int J Radiat Oncol Biol Phys. 57: S172-3, 2003.

120. Pollack A, Grignon DJ, Heydon KH, Hammond EH, Lawton CA, Mesic JB, Fu KK, Porter AT, Abrams RA and Shipley WU: Prostate cancer DNA ploidy and response to salvage hormone therapy after radiotherapy with or without short-term total androgen blockade: an analysis of RTOG 8610. J Clin Oncol. 21: 1238-48, 2003.

121. Rahman KM, Aranha O and Sarkar FH: Indole-3-carbinol (I3C) induces apoptosis in tumorigenic but not in nontumorigenic breast epithelial cells. Nutr Cancer. 45: 101-12, 2003.

122. Reddy KB, Nabha SM and Atanaskova N: Role of MAP kinase in tumor progression and invasion. Cancer Metastasis Rev. 22: 395-403, 2003.

123. Reddy RC, Keshamouni VG, Jaigirdar SH, Zeng X, Leff T, Thannickal VJ and Standiford TJ: Deactivation of murine alveolar macrophages by peroxisome proliferator-activated receptor-gamma ligands. Am J Physiol Lung Cell Mol Physiol. 286: L613-9, 2004.

124. Redline RW, Faye-Petersen O, Heller D, Qureshi F, Savell V and Vogler C: Amniotic Infection Syndrome: Nosology and Reproducibility of Placental Reaction Patterns. Pediatr Dev Pathol, 2003.

125. Riss D, Jin L, Qian X, Bayliss J, Scheithauer BW, Young WF, Jr., Vidal S, Kovacs K, Raz A and Lloyd RV: Differential expression of galectin-3 in pituitary tumors. Cancer Res. 63: 2251-5, 2003.

126. Roach M, 3rd, Lu J, Pilepich MV, Asbell SO, Mohiuddin M and Grignon D: Race and survival of men treated for prostate cancer on radiation therapy oncology group phase III randomized trials. J Urol. 169: 245-50, 2003.

127. Rosenblum G, Meroueh SO, Kleifeld O, Brown S, Singson SP, Fridman R, Mobashery S and Sagi I: Structural basis for potent slow binding inhibition of human matrix metalloproteinase-2 (MMP-2). J Biol Chem. 278: 27009-15, 2003.

128. Rotenberg RG, Rozas NS, Guerri L, Cher ML, Gamboni M, Lema N and Bonfil RD: Elevated levels of angiostatin in effusions from patients with malignant disease. Oncol Rep. 11: 523-8, 2004.

129. Sakr WA and Lucia MS: Potential pathologic markers for prostate chemoprevention studies. Urol Clin North Am. 31: 227-35, 2004.

130. Sakr WA: Epidemiology of prostate cancer and its precursors. Mod Pathol, 2004.

131. Sarkar FH and Li Y: Soy isoflavones and cancer prevention. Cancer Invest. 21: 744-57, 2003.

132. Sarkar FH, Rahman KM and Li Y: Bax translocation to mitochondria is an important event in inducing apoptotic cell death by indole-3-carbinol (I3C) treatment of breast cancer cells. J Nutr. 133: 2434S-2439S, 2003.

133. Sawyer JR, Husain M, Lukacs JL, Stangeby C, Binz RL and Al-Mefty O: Telomeric fusion as a mechanism for the loss of 1p in meningioma. Cancer Genet Cytogenet. 145: 38-48, 2003.

134. Sawyer JR, Sammartino G, Husain M and Linskey ME: Constitutional t(16;22)(p13.3;q11.2 approximately 12) in a primitive neuroectodermal tumor of the pineal region. Cancer Genet Cytogenet. 142: 73-6, 2003.

135. Scharovsky OG, Binda MM, Rozados VR, Bhagat S, Cher ML and Bonfil RD: Angiogenic and antiangiogenic balance regulates concomitant antitumoral resistance. Clin Exp Metastasis. 21: 177-83, 2004.

136. Schiemann WP, Rotzer D, Pfeifer WM, Levi E, Rai KR, Knaus P and Kadin ME: Transforming growth factor-beta (TGF-beta)-resistant B cells from chronic lymphocytic leukemia patients contain recurrent mutations in the signal sequence of the type I TGF-beta receptor. Cancer Detect Prev. 28: 57-64, 2004.

137. Schmidt RE, Dorsey DA, Beaudet LN, Parvin CA, Zhang W and Sima AA: Experimental rat models of types 1 and 2 diabetes differ in sympathetic neuroaxonal dystrophy. J Neuropathol Exp Neurol. 63: 450-60, 2004.

138. Schwartz KL, Kulwicki A, Weiss LK, Fakhouri H, Sakr W, Kau G and Severson RK: Cancer among Arab Americans inthe metropolitan Detroit area. Ethn Dis. 14: 141-6, 2004.

139. Shah JR, Juhasz C, Kupsky WJ, Asano E, Sood S, Fain D and Chugani HT: Rasmussen encephalitis associated with Parry-Romberg syndrome. Neurology. 61: 395-7, 2003.
140. Shaman MA, Zak IT and Kupsky WJ: Best cases from the AFIP: Involuted sclerotic meningioma. Radiographics. 23: 785-9, 2003.

141. Shehadeh NJ, Vernick J, Lonardo F, Madan SK, Jacobs JR, Yoo GH, Kim HE and Ensley JF: Sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid: a case report and review of the literature. Am J Otolaryngol. 25: 48-53, 2004.

142. Sheng S: Maspin and the order of signaling. Cancer Biol Ther. 2: 404-5, 2003.

143. Sima AA, Li ZG and Zhang W: The insulin-like growth factor system and neurological complications in diabetes. Exp Diabesity Res. 4: 235-56, 2003.

144. Sima AA and Shafrir E: Editorial. Int J Exp Diabesity Res. 4: I, 2003.

145. Sima AA: New insights into the metabolic and molecular basis for diabetic neuropathy. Cell Mol Life Sci. 60: 2445-64, 2003.

146. Sima AA: C-peptide and diabetic neuropathy. Expert Opin Investig Drugs. 12: 1471-88, 2003.

147. Sima AA, Zhang W and Grunberger G: Type 1 diabetic neuropathy and C-peptide. Exp Diabesity Res. 5: 65-77, 2004.

148. Sima AA, Zhang W, Li ZG, Murakawa Y and Pierson CR: Molecular alterations underlie nodal and paranodal degeneration in type 1 diabetic neuropathy and are prevented by C-Peptide. Diabetes. 53: 1556-63, 2004.

149. Sima AA: Diabetic neuropathy in type 1 and type 2 diabetes and the effects of C-peptide. J Neurol Sci. 220: 133-6, 2004.

150. Sima AA, Kamiya H and Li ZG: Insulin, C-peptide, hyperglycemia, and central nervous system complications in diabetes. Eur J Pharmacol. 490: 187-97, 2004.

151. Spears JR, Prcevski P, Xu R, Li L, Brereton G, DiCarli M, Spanta A, Crilly R, Lavine S and Vander Heide R: Aqueous oxygen attenuation of reperfusion microvascular ischemia in a canine model of myocardial infarction. Asaio J. 49: 716-20, 2003.

152. Stevens MJ, Zhang W, Li F and Sima AA: C-Peptide Corrects Endoneurial Blood Flow but Not Oxidative Stress in Type 1 Bb/Wor-Rats. Am J Physiol Endocrinol Metab, 2004.

153. Sumigama S, Ito T, Kajiyama H, Shibata K, Tamakoshi K, Kikkawa F, Williams T, Tainsky MA, Nomura S and Mizutani S: Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cells by overexpression of AP-2alpha. Oncogene, 2004.

154. Takenaka Y, Inohara H, Yoshii T, Oshima K, Nakahara S, Akahani S, Honjo Y, Yamamoto Y, Raz A and Kubo T: Malignant transformation of thyroid follicular cells by galectin-3. Cancer Lett. 195: 111-9, 2003.

155. Takenaka Y, Fukumori T, Yoshii T, Oka N, Inohara H, Kim HR, Bresalier RS and Raz A: Nuclear export of phosphorylated galectin-3 regulates its antiapoptotic activity in response to chemotherapeutic drugs. Mol Cell Biol. 24: 4395-406, 2004.

156. Takenaka Y, Fukumori T and Raz A: Galectin-3 and metastasis. Glycoconj J. 19: 543-9, 2004.

157. Takeuchi T, Heng HH, Ye CJ, Liang SB, Iwata J, Sonobe H and Ohtsuki Y: Down-regulation of a novel actin-binding molecule, skeletrophin, in malignant melanoma. Am J Pathol. 163: 1395-404, 2003.

158. Toth M, Chvyrkova I, Bernardo MM, Hernandez-Barrantes S and Fridman R: Pro-MMP-9 activation by the MT1-MMP/MMP-2 axis and MMP-3: role of TIMP-2 and plasma membranes. Biochem Biophys Res Commun. 308: 386-95, 2003.

159. Tsutsumi S, Gupta SK, Hogan V, Tanaka N, Nakamura KT, Nabi IR and Raz A: The enzymatic activity of phosphoglucose isomerase is not required for its cytokine function. FEBS Lett. 534: 49-53, 2003.

160. Tsutsumi S, Hogan V, Nabi IR and Raz A: Overexpression of the autocrine motility factor/phosphoglucose isomerase induces transformation and survival of NIH-3T3 fibroblasts. Cancer Res. 63: 242-9, 2003.

161. Ullah N, Qureshi K, Hatfield J, Sochacki P, David D, Albataineh H, Mejia L, Kenkre C, Lawson M and Tobi M: Small early tubular adenomas and mixed colonic polyps found on screening flexible sigmoidoscopy do not predict proximal neoplasia in males. Clin Gastroenterol Hepatol. 2: 246-51, 2004.

162. Ustach CV, Taube ME, Hurst NJ, Jr., Bhagat S, Bonfil RD, Cher ML, Schuger L and Kim HR: A potential oncogenic activity of platelet-derived growth factor d in prostate cancer progression. Cancer Res. 64: 1722-9, 2004.

163. Van Heek NT, Maitra A, Koopmann J, Fedarko N, Jain A, Rahman A, Iacobuzio-Donahue CA, Adsay V, Ashfaq R, Yeo CJ et al.: Gene Expression Profiling identifies Markers of Ampullary Adenocarcinoma. Cancer Biol Ther. 3, 2004.

164. Varani J, Schuger L, Dame MK, Leonard C, Fligiel SE, Kang S, Fisher GJ and Voorhees JJ: Reduced fibroblast interaction with intact collagen as a mechanism for depressed collagen synthesis in photodamaged skin. J Invest Dermatol. 122: 1471-9, 2004.

165. Vasef MA, Ubaidat MA, Khalidi HS, Almasri NM, Al-Abbadi M and Annab HZ: Association between Epstein-Barr virus and classic Hodgkin lymphoma in Jordan: a comparative study with Epstein-Barr virus-associated Hodgkin lymphoma in North America. South Med J. 97: 273-7, 2004.

166. Vasquez JC, Rabah R, Delius RE and Walters HL: Hypoplastic left heart syndrome with intact atrial septum associated with deletion of the short arm of chromosome 18. Cardiovasc Pathol. 12: 102-4, 2003.

167. Wei H, L'Ecuyer T and Vander Heide RS: Effect of increased expression of cytoskeletal protein vinculin on ischemia-reperfusion injury in ventricular myocytes. Am J Physiol Heart Circ Physiol. 284: H911-8, 2003.

168. Wu YI, Munshi HG, Sen R, Snipas SJ, Salvesen GS, Fridman R and Stack MS: Glycosylation broadens the substrate profile of membrane type 1 matrix metalloproteinase. J Biol Chem. 279: 8278-89, 2004.

169. Yang Y, Zhe X, Phan SH, Ullenbruch M and Schuger L: Involvement of serum response factor isoforms in myofibroblast differentiation during bleomycin-induced lung injury. Am J Respir Cell Mol Biol. 29: 583-90, 2003.

170. Yang LV, Heng HH, Wan J, Southwood CM, Gow A and Li L: Alternative promoters and polyadenylation regulate tissue-specific expression of Hemogen isoforms during hematopoiesis and spermatogenesis. Dev Dyn. 228: 606-16,2003.

171. Yang XJ, Sugimura J, Tretiakova MS, Furge K, Zagaja G, Sokoloff M, Pins M, Bergan R, Grignon DJ, Stadler WM et al.: Gene expression profiling of renal medullary carcinoma: potential clinical relevance. Cancer. 100: 976-85, 2004.

172. Yang XJ, Sugimura J, Tretiakova MS, Furge K, Zagaja G, Sokoloff M, Pins M, Bergan R, Grignon DJ, Stadler WM et al.: Gene expression profiling of renal medullary carcinoma: potential clinical relevance. Cancer. 100: 976-85, 2004.

173. Zhang Y, Dawson MI, Ning Y, Polin L, Parchment RE, Corbett T, Mohamed AN, Feng KC, Farhana L, Rishi AK et al.: Induction of apoptosis in retinoid-refractory acute myelogenous leukemia by a novel AHPN analog. Blood. 102: 3743-52, 2003.

174. Zhang H, Lucas DR, Pass HI and Che M: Disseminated malignant solitary fibrous tumor of the pleura. Pathol Int. 54: 111-5, 2004.

175. Zhao H, Bernardo MM, Osenkowski P, Sohail A, Pei D, Nagase H, Kashiwagi M, Soloway PD, DeClerck YA and Fridman R: Differential inhibition of membrane type 3 (MT3)-matrix metalloproteinase (MMP) and MT1-MMP by tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-3 rgulates pro-MMP-2 activation. J Biol Chem. 279: 8592-601, 2004.

176. Zhe X, Yang Y, Jakkaraju S and Schuger L: Tissue inhibitor of metalloproteinase-3 downregulation in lymphangioleiomyomatosis: potential consequence of abnormal serum response factor expression. Am J Respir Cell Mol Biol. 28: 504-11, 2003.

177. Zhong L, Wang Y, Kannan P and Tainsky MA: Functional characterization of the interacting domains of the positive coactivator PC4 with the transcription factor AP-2alpha. Gene. 320: 155-64, 2003.

178. Zonder JA, Pemberton P, Brandt H, Mohamed AN and Schiffer CA: The effect of dose increase of imatinib mesylatein patients with chronic or accelerated phase chronic myelogenous leukemia with inadequate hematologic or cytogenetic response to initial treatment. Clin Cancer Res. 9: 2092-7, 2003.